Artisan Partners
EWTX icon

Artisan Partners’s Edgewise Therapeutics EWTX Stock Holding History

Artisan Partners’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.8M Sell
659,067
-45,010
-6% -$1.3M 0.03% 281
2025
Q4 		$17.5M Sell
704,077
-14,098
-2% -$283K 0.03% 301
2025
Q3 		$11.6M Sell
718,175
-660,893
-48% -$9.37M 0.02% 304
2025
Q2 		$18.1M Buy
1,379,068
+461,846
+50% +$6.66M 0.03% 295
2025
Q1 		$20.2M Sell
917,222
-154,374
-14% -$4.05M 0.03% 282
2024
Q4 		$28.6M Buy
1,071,596
+70,964
+7% +$2.26M 0.04% 284
2024
Q3 		$26.7M Buy
+1,000,632
New +$19.9M 0.04% 273

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Artisan Partners's EWTX Position: Q1 2026 in Review

Artisan Partners reduced its Edgewise Therapeutics (EWTX) stake by 6.4% in Q1 2026, selling an estimated $1.3M and leaving 659,067 shares worth $20.8M. The position accounts for 0.03% of the portfolio, ranked #281.

Artisan Partners first reported a position in EWTX in Q3 2024 and has held it in 7 quarters since. The position peaked at $28.6M in Q4 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Artisan Partners held 659,067 shares of Edgewise Therapeutics worth $20.8M as of Q1 2026.
  • Artisan Partners sold 45,010 Edgewise Therapeutics shares in Q1 2026, an estimated $1.3M.
  • Edgewise Therapeutics made up 0.03% of Artisan Partners's portfolio in Q1 2026, its #281 holding.
  • Artisan Partners first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Artisan Partners's Edgewise Therapeutics position peaked at $28.6M in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Artisan Partners's 13F filing for Q1 2026, filed 13 May 2026.